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Sleep difﬁculties and short sleep duration have been associated with hypertension. Though body mass index (BMI) may be a
mediator variable, the mediation effect has not been deﬁned. We aimed to assess the association between sleep duration and
sleep difﬁculties with hypertension, to determine if BMI is a mediator variable, and to quantify the mediation effect. We con-
ducted a mediation analysis and calculated prevalence ratios with 95% conﬁdence intervals. The exposure variables were
sleep duration and sleep difﬁculties, and the outcome was hypertension. Sleep difﬁculties were statistically signiﬁcantly asso-
ciated with a 43% higher prevalence of hypertension in multivariable analyses; results were not statistically signiﬁcant for
sleep duration. In these analyses, and in sex-speciﬁc subgroup analyses, we found no strong evidence that BMI mediated
the association between sleep indices and risk of hypertension. Our ﬁndings suggest that BMI does not appear to mediate
the association between sleep patterns and hypertension. These results highlight the need to further study the mechanisms
underlying the relationship between sleep patterns and cardiovascular risk factors.
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Introduction
To lessen the global burden of cardiovascular diseases, it is
crucial that rates of hypertension and other cardiovascular
risk factors are reduced [1, 2]. Studying the biological
mechanisms underlying the risk factors for hypertension is
needed to design more effective interventions to manage
hypertension. Important risk factors for hypertension
include short sleep duration and sleep difﬁculties [3–5].
Experimental studies have shown that acute sleep restriction
is associated with higher blood pressure during the night and
morning, as well as associated with higher sensitivity of
arterial baroreﬂex responses [6]. Moreover, randomized
controlled trials have shown a reduction in blood pressure
as well as in cardiovascular events in patients with obstruct-
ive sleep apnea treated with continuous positive airway
pressure [7, 8]. Nevertheless, these studies did not include
weight management as a key treatment to improve the effect
of sleep health on blood pressure. It has been suggested that
body mass index (BMI) and obesity are partial mediators of
the association between hypertension and sleep duration
[9–11]. It has been demonstrated that sleep restriction
leads to an imbalance of appetite-regulating hormones that
may result in increased food intake [6]. The increased hun-
ger may be satisﬁed by unhealthy food choices that impair
cardiovascular health, which could potentially increase
arterial stiffness, an effect that is also caused by sleep pro-
blems themselves [12].
Mediation analyses are important to disentangle the mag-
nitude of an exposure’s effect that may be explained by
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another variable [13]. To obtain a better understanding of
the effect of sleep duration and sleep difﬁculties on hyper-
tension, it is important to assess what mediator variables
may exist in this pathway and how much of the direct effect
they explain.
In many developing countries, like Peru, the prevalence of
hypertension differs within the country, highlighting the
need to perform epidemiological studies in a variety of set-
tings [14, 15]. Studies on the association between sleep dur-
ation or difﬁculties and hypertension have been conducted
mostly in developed countries, with the exception of
Brazil [3, 9, 16]. Complementing the available evidence
with results from resource-constrained settings in develop-
ing countries – where risk factors, exposures, and health
outcomes have different distributions compared with devel-
oped countries – is much needed. While it has been
reported that Peruvians have adequate sleep duration [17],
there is a lack of information on the association between
sleep patterns and hypertension, or the possible role of
BMI in any observed association. Consequently, we aimed
to estimate the association between sleep duration and
sleep difﬁculties with hypertension, and to assess and quan-
tify any mediation effect of BMI, on more than 2300 indivi-
duals in Peru.
Methods
Study design and data source
This is a secondary analysis of the baseline assessment of an
implementation study in Peru. Further details about the
implementation study have been published elsewhere [18].
Brieﬂy, the study was conducted in six villages in Tumbes,
a region in Northern Peru and at sea level. Tumbes is a semi-
urban setting where areas traditionally used for agricultural
and ﬁshing are undergoing urbanization [18]. Current statis-
tics (2013) indicate a total population of 237 685 people, and
the 3.5% of them have no formal education. In 2012, 61.2%
of the population had health insurance. As much as 14.4% of
the population was considered poor and 1.4% extremely
poor.
Participants
Eligible subjects were identiﬁed from the most updated cen-
sus of six randomly selected villages, out of 20 potential vil-
lages in which there were between 300 and 600 inhabitants.
Participants were 18+ years old, full-time residents in the
area, and capable of understanding procedures and giving
informed consent. All houses were approached, and all eli-
gible members of a household were included. Exclusion cri-
teria included having any mental illness preventing the
participant from providing informed consent, as well as self-
reported diagnosis of chronic kidney disease or heart dis-
ease, as required in the original implementation study [18].
The sample was selected to participate in an implementation
study, and it is not representative of the whole area or
Tumbes.
Variables
Further details on data collection procedures have been
published elsewhere [18]. Brieﬂy, clinical evaluations were
performed by trained health personnel and included blood
pressure, height and weight measurements in each house-
hold. Blood pressure was measured three times after a
5-min resting period, and the mean of the last two measure-
ments was used for the analysis. Participants were not fast-
ing or off medication. Standard and calibrated devices
(OMRON HEM-780, Tokyo, Japan) were used throughout
the data collection process. All other variables were
assessed with standardized questionnaires. All the study sub-
jects answered the same questionnaires, which included
domains from the WHO STEPS approach questionnaire
(questions about alcohol consumption and smoking) and
the short version of the IPAQ (physical activity questions).
Outcome variable
The outcome variable was a binary variable that indicated if
hypertension was present (yes/no), deﬁned as one or more
of the following: (a) systolic blood pressure ≥140 mmHg, (b)
diastolic blood pressure ≥90 mmHg, (c) self-report of phys-
ician diagnosis, or (d) current use of antihypertensive medi-
cation [19].
Exposure variables
There were two exposure variables of interest: short sleep
duration and sleep difﬁculties. Each exposure of interest was
subject of a separate mediation analysis. Sleep duration was
assessed with the question: On average, in the last year, how
many hours did you sleep in an average day (including naps)?
Sleep duration was deﬁned using the cut-off points as per
National Sleep Foundation recommendations [20]: the ref-
erence was sleeping between 7 and 9 h for adults, and
between 7 and 8 h for older adults (aged 65+). Individuals
who obtained less or more sleep duration were categorized
as having short or long sleep duration, respectively.
Based on similar deﬁnitions in previous studies [21–23],
sleep difﬁculties were deﬁned with a combination of two
questions: During the last month, have you had difﬁculty falling
asleep? and During the last month, how frequently have you
woken up during the night? Possible answers to each question
were: almost never, sometimes, and frequently. Participants
who answered sometimes or frequently to both questions
were classiﬁed as having sleep difﬁculties; those who
answered almost never to both questions were considered
not to have sleep difﬁculties.
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Other variables
Other variables included sex; age (18–29, 30–44, 45–60,
60+); assets index (in tertiles) based on assets and house-
hold facilities; physical activity assessed with the IPAQ
(International Physical Activity Questionnaire) and classiﬁed
as low, moderate, or high [24]; heavy drinker, deﬁned as
having a hangover or ≥6 drinks on the same occasion at
least once per month (yes/no); current smoker (yes/no);
depression assessed with the PHQ-9 (Patient Health
Questionanire-9) score and classiﬁed as ≥15 or <15
because this cut-off has the highest speciﬁcity [25]; obesity
as BMI ≥30 kg/m2; and village in which the participant
lived. BMI (kg/m2) as a numerical continuous variable was
assessed as a mediator variable. Sex was assessed in inter-
action analyses to explore whether the associations of inter-
est varied among men and women.
Statistical methods
All analyses were conducted using Stata version 13.0
(STATA Corp, College Station, Texas, USA). To describe
numerical variables, we used means and standard deviations
(S.D.), and to describe categorical variables, we used propor-
tions with 95% conﬁdence intervals (95% CIs). To compare
numerical variables, we used the two-sample t test, and to
compare categorical variables, we used the χ2 test.
Prevalence ratios (PR) and 95% CI were calculated using
generalized linear models with robust variance to account
for the cluster effect due to more than one member per
household. The PR has a similar interpretation as odds
ratio, but they give more conservative results in cross-
sectional studies [26]. Regression models were constructed
as depicted in Fig. 1. In addition, an adjusted model was ﬁt-
ted including all other variables apart from BMI. The
adjusted model, including obesity, was ﬁtted to assess if
there was association between sleep duration or difﬁculties
and hypertension, independent of potential confounders.
Because previous studies have reported different results
in the association between sleep indicators and hyperten-
sion for men and women [3, 5], we assessed if the regres-
sion model including a multiplicative interaction between
sex and the sleep indicator was better than a mode with
either one independently. The after estimation likelihood-
ratio test was used. However, regardless of the interaction
results, regression models were stratiﬁed by sex for com-
parison purposes. In these stratiﬁed models, sex was not
included as a co-variable.
In order to determine if BMI was a mediator of the asso-
ciation between the sleep duration or sleep difﬁculties and
hypertension, we ﬁrst explored mediation with a set of
equations (Fig. 1) [26]. A mediator variable stands in the
causal path between an exposure and an outcome. In add-
ition, the mediator variable affects the outcome and is itself
affected by the exposure [27]. Mediation analyses were con-
ducted for the two exposure variables, and separately by
sex. To quantify the mediation effect, we used the ldecomp
command in STATA, which decomposes the total effect
into direct and indirect effects [28].
Ethics
Ethical approval was obtained from two Institutional Review
Boards: Universidad Peruana Cayetano Heredia in Peru
and Johns Hopkins University in the USA. The original
implementation study was registered in ClinicalTrials.gov
(NCT01960972). The authors assert that all procedures
contributing to this work comply with the ethical standards
of the relevant national and institutional committees on
human experimentation and with the Helsinki Declaration
of 1975, as revised in 2008.
Results
Participants
At baseline, a total of 2376 individuals were evaluated, and
the 1.6% was excluded due to missing data, leaving full
data available for 2338 participants. The participant mean
age was 43.3 (S.D. 17.2) years, and 50.7% of the study popu-
lation were women. On average, participants slept 7.8 (S.D.:
1.3) h, and 24.4% (95% CI 22.7–26.2%) reported having
sleep difﬁculties (Table 1). The overall prevalence of hyper-
tension was 18.2% (95% CI 16.7–19.8%). Table 2 shows par-
ticipants’ characteristics by hypertension status.
When sleep duration was the exposure of interest, a
model including its interaction with sex was not better
than the simple regression model (p = 0.97); likewise,
Figure 1 Diagram for the mediation analysis. Baron and Kenny
deﬁned a set of models that must be met to deﬁne a mediator
variable [26]: (i) there is a signiﬁcant association between the
exposure and the outcome (path A); (ii) there is a signiﬁcant
association between the exposure and the mediator (path B);
(iii) including the exposure and mediator in the model, there is a
reduction of the association estimate between the exposure and
outcome (estimates in path D < path A). These requisites for
paths A, B, and D should be met to consider a variable to be a
mediator.
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when the model used sleep difﬁculties as the exposure,
including the interaction term did not improve it (p = 0.24).
Short sleep duration and hypertension
Relative to subjects with hypertension, we found that indivi-
duals reporting the recommended sleep duration were
more likely to be normotensive (p < 0.001, Table 2). In
the adjusted model, including men and women, there was
no association between short sleep duration and hyperten-
sion: PR = 1.21 (95% CI 0.99–1.49, Table 3).
Sleep difﬁculties and hypertension
We found that sleep difﬁculties were strongly associated
with hypertension (p < 0.001, Table 2). In the multivariable
model when compared with individuals without sleep difﬁ-
culties, and including both men and women, there was
43% higher prevalence of hypertension among those with
sleep difﬁculties (Table 3). When the results were stratiﬁed
by sex, this association only remained among women with
68% higher prevalence (Table 3).
Mediation analysis
In combined analyses of men and women, and according to
our deﬁnition, BMI was not a mediator of either the associa-
tions of interest. In sex-speciﬁc analyses, we found that BMI
partly mediated the association between short sleep dur-
ation and hypertension in men only (Table 3): among men,
BMI accounted for 18.6% of the effect of short sleep dur-
ation on hypertension.
Discussion
Main results
In our sample of 2338 Peruvian men and women living in a
resource-limited setting, we found evidence of an increased
prevalence of hypertension among those with sleep difﬁcul-
ties (difﬁculties to fall asleep and waking-up at night), but not
with short sleep duration (<7 h). The results also suggested
that either association of interest did not change according
to sex. In the overall model, BMI could not be classiﬁed as
a mediator variable; however, BMI seems to be a partial
mediator of the association between sleep duration and
hypertension in men only. Because the results are not con-
clusive to draw strong recommendations, they should be
veriﬁed by future studies aiming to assess this, and other
potential mediators, following more comprehensive meth-
ods in cross-sectional and prospective studies.
Comparison with previous studies
There is evidence of an association between short sleep dur-
ation and hypertension from both prospective [3, 4, 29], and
cross-sectional studies [3, 5]. However, several cross-
sectional [3, 5] studies reported no association while others
found the association is sex-dependent or only in a particu-
lar age range [3, 5, 9]. Of particular interest, a cross-
sectional study in the USA with a Hispanic population
reported that short sleep duration was not associated
with hypertension [30]. Dissimilar results may be explained
by greater mean age in some studies [3, 5, 21], different dis-
tribution of the variables of interest (i.e. hypertension, short
sleep duration) [17], and differences in environmental
Table 1. Self-reported sleep duration and sleep difﬁculties
Sleep patterns
% (95% CI)
Overall Women Men
Sleep durationa N = 2338 N = 1185 N = 1153
7–9 h 73.1 (71.2–74.8) 76.9 (74.4–79.1) 69.1 (66.4–71.7)
<7 h 15.3 (13.9–16.8) 10.5 (8.8–12.3) 20.2 (18.0–22.6)
>9 h 11.7 (10.4–13.0) 12.7 (10.9–14.7) 10.7 (9.0–12.6)
Sleep difﬁculties N = 2303 N = 1169 N = 1134
No 75.6 (73.8–77.3) 70.7 (68.1–73.3) 80.6 (78.2–82.8)
Yes 24.4 (22.7–26.2) 29.3 (26.7–31.9) 19.4 (17.2–21.8)
Difﬁculties getting to sleep N = 2338 N = 1185 N = 1153
Almost never 75.7 (73.9–77.4) 71.0 (68.3–73.5) 80.6 (78.2–82.8)
Sometimes 20.4 (18.8–22.1) 24.1 (21.7–26.6) 16.7 (14.6–18.9)
Frequently 3.9 (3.2–4.8) 5.0 (3.9–6.4) 2.8 (2.0–3.9)
Waking up at night N = 2338 N = 1185 N = 1153
Almost never 74.7 (72.9–76.4) 70.0 (67.3–72.5) 79.6 (77.2–81.9)
Sometimes 21.3 (19.7–23.0) 24.9 (22.5–27.4) 17.6 (15.5–19.9)
Frequently 4.0 (3.3–4.9) 5.2 (4.0–6.6) 2.8 (2.0–3.9)
a Recommended sleep duration deﬁned as 7–9 h for adults aged 65 years and under, and 7–8 h for adults aged 65+ years old.
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factors, such as pollution or noise [31]. Further research
should be conducted on the role of environmental factors
in the association between sleep (duration or problems)
and hypertension in developing settings undergoing
urbanization.
Some prospective studies have reported that sleep difﬁ-
culties are associated with a higher risk of hypertension
[4], and yet conclusive results were not retrieved by other
cross-sectional studies using our same deﬁnition of sleep dif-
ﬁculties [21–23]. However, some of the studies with a pro-
spective design included a third component in their sleep
difﬁculties deﬁnition: waking up too early in the morning.
We did not include this component, which could explain
the different results. This may imply that each component
has a different effect on the association estimates. In fact,
prospective studies have reported different risk estimates
for hypertension using each of the three components indi-
vidually as well as in different combinations [32, 33].
Overall, we found similar association estimates for each
component of the sleep difﬁculties deﬁnition. Thus, the
third component could have radically changed the estimates.
This warrants veriﬁcation in a similar population to that one
in this study.
Interpretation of results
Overall, we found that hypertension was associated with
sleep difﬁculties, but not with short sleep duration. This
could indicate that these risk factors may be linked to hyper-
tension through different pathways [4]. In the overall model,
BMI did not prove to be mediator variable, thus other
potential mediators need to be explored. However, our
results suggest that BMI partially mediates the association
between sleep duration and hypertension in men only; this
could suggest that the causal pathways between the two
exposures of interest and hypertension may be different
for men and women. This is relevant as there is still room
to study sleep difﬁculties, or symptoms of other sleep disor-
ders (e.g. restless legs syndrome, sleep apnea, periodic limb
movement disorder, etc.), in terms of the physiological
pathways that lead to hypertension [34, 35]. For example,
insomnia leads to a hyper-arousal state in which the sympa-
thetic nervous system activity is increased; when the central
nervous system is chronically activated, subjects are at
higher risk for cardiovascular events [34]. Unlike short
sleep duration, sleep disorders require the development of
interventions beyond the simple recommendation to sleep
longer or at least what is suggested for the age range [20].
Consequently, further studies should be conducted to con-
ﬁrm the mediation effect of BMI according to sex. This
would help to display gender-speciﬁc interventions for
each exposure herein assessed.
Conducting a mediation analysis gives evidence on what
variables account for the effect of a given exposure on an
outcome of interest (indirect effect). Our results do not sup-
port the hypothesis that BMI is a mediator in the associations
of interest including both men and women. Nevertheless,
and although preliminarily, our results suggest that BMI
could be a mediator in men only; this observation warrants
careful interpretation as well as further veriﬁcation.
Table 2. Characteristics of the study population according to
hypertension status
Variable Hypertension p
a
No Yes
Age (years) n = 1912 n = 426
18–29 31.4 4.7 <0.001
30–44 36.4 16.7
45–59 20.2 30.5
60+ 12.0 48.1
Mean age (years) 39.9 (±15.3) 59.0 (±16.8) <0.001
Sex n = 1912 n = 426
Female 49.1 57.8 0.001
Male 50.9 42.3
Assets index n = 1876 n = 419
Bottom 28.8 32.0 0.238
Middle 34.3 30.3
Top 36.8 37.7
Physical activity n = 1912 n = 426
Low 65.1 73.2 <0.001
Moderate 25.0 22.1
High 10.0 4.7
Heavy drinker n = 1912 n = 426
No 93.0 95.8 0.038
Yes 7.0 4.2
Current smoker n = 1902 n = 425
No 88.2 91.8 0.036
Yes 11.8 8.2
Depression n = 1912 n = 426
No 98.2 97.7 0.434
Yes 1.8 2.4
BMI (kg/m2) 26.9 (± 4.5) 28.7 (±4.7) <0.001
Obesity n = 1868 n = 415
No 77.6 62.9 <0.001
Yes 22.4 37.1
Sleep (hours) 7.8 (± 1.3) 7.7 (±1.4) 0.061
Sleep duration n = 1912 n = 426
Suggestedb 75.0 64.6 <0.001
Less than suggested 14.2 20.2
More than suggested 10.9 15.3
Sleep difﬁculties n = 1882 n = 421
No 79.3 58.9 <0.001
Yes 20.7 41.1
a χ2 (categorical variables) or two-sample t test (continuous
variables).
b Recommended sleep duration deﬁned as 7–9 h for adults aged
65 years and under, and 7–8 h for adults aged 65+ years old.
Percentages are presented for categorical variables, while for
numerical variables the mean (±S.D.) is depicted.
cambridge.org/gheg
https://www.cambridge.org/core/terms. https://doi.org/10.1017/gheg.2017.10
Downloaded from https://www.cambridge.org/core. London School of Hygiene & Tropical Medicine, on 16 Feb 2018 at 09:34:47, subject to the Cambridge Core terms of use, available at
The role of BMI in the association between sleep (dur-
ation and problems) with hypertension should not be negli-
gible; nevertheless, further studies must be conducted to
verify our results before strong recommendations are
made for subjects in developing countries. Furthermore,
there is a need to study what other mediator variables are
there in the associations of interest, and which ones have
the greatest indirect effect, so can be subject of primary pre-
vention strategies.
This work included a population undergoing epidemio-
logical transition and urbanization. Similar populations have
not been much included in epidemiological studies linking
sleep and health outcomes. Therefore, our results under-
score the importance of improving sleep health in resource-
limited settings to minimize their negative health effects.
This could be achieved by directly addressing sleep health
or by addressing the mediator that impair it.
Strengths and limitations
The main strength of the study is the large sample size of a
resource-limited setting, using standardized techniques for
measuring height, weight, and blood pressure that poten-
tially allow comparability with other studies.
This study also had several limitations. First, the cross-
sectional design does not rule out reverse causation.
Future studies should follow a prospective design to conﬁrm
the long-term effect of BMI as a partial mediator of the asso-
ciations of interest. Moreover, the mediation effect of BMI in
the association between sleep patterns and hypertension
should be further explored considering environmental vari-
ables, such as noise and air pollution [31]. Second, informa-
tion about sleep duration and difﬁculties was self-reported.
Self-reported information could have resulted in recall
bias, particularly as the questions for some variables
required the participant to remember events from the last
year (e.g. sleep duration). This limitation, shared with
other studies, could be addressed in future studies by
using other methods such as 24-h diaries [3, 4, 9]. The gold-
standard method would be to conduct a polysomnography
study, though this can be challenging in population-based
studies with a large sample size in remote settings.
Although the exposures of interest relied on self-reported
data, it has been suggested that there is a moderate correl-
ation between subjectively measured and objectively mea-
sured sleep duration [36]. On top of that, Lauderdale
et al. found that subjects who sleep 5 h report sleeping
1.2 h more [36]. Thus, our results are conservative and
Table 3. Association between short sleep duration or sleep difﬁculties and hypertension
PR (95% CI)
Path A Path B Path C Path D Adjusted model
Overall
Sleep duration (reference:
suggested sleep duration)
n = 2066 n = 2044 n = 2316 n = 2044 n = 1976
Less than suggested 1.48 (1.19–1.84) 1.44 (0.86–2.42) 1.07 (1.05–1.09) 1.47 (1.18–1.82) 1.21 (0.99–1.49)
Sleep difﬁculties (reference: no) n = 2306 n = 2281 n = 2316 n = 2281 n = 2202
Yes 2.14 (1.81–2.53) 1.32 (0.84–2.07) 1.07 (1.05–1.09) 2.09 (1.77–2.47) 1.43 (1.22–1.68)
Women
Sleep duration (reference:
suggested sleep duration)
n = 1036 n = 1020 n = 1167 n = 1020 n = 980
Less than suggested 1.60 (1.18–2.17) 1.05 (0.41–2.64) 1.05 (1.03–1.07) 1.62 (1.19–2.19) 1.11 (0.82–1.51)
Sleep difﬁculties (reference: no) n = 1170 n = 1151 n = 1167 n = 1151 n = 1106
Yes 2.30 (1.85–2.87) 1.24 (0.67–2.29) 1.05 (1.03–1.07) 2.31 (1.86–2.88) 1.68 (1.36–2.07)
Men
Sleep duration (reference:
suggested sleep duration)
n = 1030 n = 1024 n = 1149 n = 1024 n = 996
Less than suggested 1.55 (1.15–2.10) 2.88 (1.61–5.17) 1.09 (1.06–1.12) 1.43 (1.06–1.95) 1.30 (0.98–1.72)
Sleep difﬁculties (reference: no) n = 1136 n = 1130 n = 1149 n = 1130 n = 1096
Yes 1.90 (1.43–2.52) 0.91 (0.47–1.73) 1.09 (1.06–1.12) 1.83 (1.37–2.43) 1.12 (0.86–1.47)
Path A, the exposure is sleep duration or sleep difﬁculties and the outcome hypertension. Path B, the exposure is sleep duration or
sleep difﬁculties and the outcome is BMI. Path C, the exposure is BMI and the outcome is hypertension. Path D, the exposure is sleep
duration or sleep difﬁculties and the outcome is hypertension, adjusted for BMI. Adjusted model included obesity status, sex, age in cat-
egories, assets index in tertiles, physical activity, heavy drinker, current smoker, and depression. All models adjusted by the village in
which the participant live. In bold are presented the statistically signiﬁcant results (p<0.05).
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draw attention as there may be a much higher prevalence
and burden of short sleep duration. In addition, sleep pat-
terns over the last ﬁve decades have a similar trajectory
assessed with objective and subjective measures [37].
Consequently, in spite of the differences between these
methods, they seem to give a similar overall picture.
Third, this is a secondary analysis, and thus the sample and
data were not exclusively collected to answer this research
question. Consequently, some of the regression estimates
could have been underpowered; likewise, there could have
been lack of power to ﬁnd a signiﬁcant interaction effect
of sex. Nevertheless, most of the estimates showed a signiﬁ-
cant association, in spite of a possible lack of power. This
calls to conﬁrm our results because the association and
mediation effect could be stronger than reported herein.
Fourth, regarding the questions to assess sleep quality,
other studies used similar questions [21–23] and we do
not believe these will operate differently in our study: the
questions are fairly easy to understand and since they
need the participant to recall the previous months, there
should be low recall bias. Fifth, our results could have chan-
ged toward the null association due to the effect of unmeas-
ured confounders, such as drug use, household crowding,
children/toddlers in the household, or shift work status.
This outlines the need to conduct more studies about
sleep health in resource-limited settings, where these fea-
tures are rather common. Some bias in mediation analysis
has been described [13, 38]. The lack of further analyses
to address these biases in mediation analysis could be a limi-
tation of this study. However, we aimed to verify if BMI was
a mediator of the association of interest and how much of
the association it represents. Conducting a complete mul-
tiple-mediator model was beyond the scope of this paper.
Conclusions
Among men and women, sleep difﬁculties, but not short
sleep duration, were associated with a higher prevalence
of hypertension; moreover, BMI did not seem to mediate
these associations. This study highlights the need to conduct
more studies relating to sleep health in resource-limited set-
tings, and to further explore BMI and other variables as pos-
sible mediators in the association between sleep health and
hypertension.
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